4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001209191-23-033141
Chief Financial Officer acquired 24,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Silberman David Chief Financial Officer | 2023-05-26 | Grant or award | +24,500 | 230,000 | D |
Loading xslF345X04/doc4.xml…